Cannabix Technol Stock Price, News & Analysis

Cannabix Technologies Inc. has successfully tested its marijuana breathalyzer technology, designed for law enforcement and workplace use, showing a strong correlation between THC levels in breath and blood plasma. This independent study, led by Dr. Phillip Olla, demonstrated that breath samples can be analyzed with Cannabix's handheld Breath Collection Unit and Mass Spectrometer within seconds, significantly reducing laboratory analysis times. The device, which requires no sample preparation, is in advanced prototype testing, aiming to enhance public safety by identifying recent marijuana use.

Cannabix Technologies has developed a Contactless Alcohol Breathalyzer (CAB) for vehicle cabins, responding to an inquiry from a major auto parts manufacturer. This prototype allows drivers to provide breath samples without a mouthpiece. The CAB technology could potentially be integrated into new safety standards mandated by the U.S. Infrastructure Investment and Jobs Act for impaired driving detection. While a provisional patent has been filed, the technology is still in preapproval stages, and no commercial sales are currently planned.

Cannabix Technologies Inc. (CSE: BLO, OTC PINK: BLOZF) is set to present its marijuana breathalyzer technology at the International Association for Chemical Testing (IACT) conference in mid-April 2022. Dr. Jared Boock will discuss THC Breath Testing Technology. The company has also shipped its new version 4.0 THC Breath Analyzers (THCBA) to beta sites for field testing. The THCBA can quickly and non-invasively test for recent THC use in under 5 minutes, enhancing safety for law enforcement and workplaces.

Cannabix Technologies is advancing marijuana breathalyzer technology aimed at enhancing public safety. At the Texas Impaired Driving Forum on February 23, 2022, Dr. Jared Boock showcased innovations in FAIMS-based detection methods for THC in breath samples. This technology could provide law enforcement with a non-invasive method for detecting recent marijuana use, addressing the growing issue of drugged driving. The Cannabix device is currently in advanced prototype and pre-clinical testing stages, with potential implications for law enforcement and employers concerned about impairment.

Cannabix Technologies Inc. has introduced its latest THC Breath Analyzer (THCBA) prototype, aimed at enhancing public safety by providing law enforcement and employers a tool for non-invasive marijuana testing. This new version incorporates design feedback to minimize variability and costs, with user testing already underway. The device can detect recent use of THC in under 5 minutes, making it more relevant than traditional methods. Planned field and clinical tests will establish benchmark standards for this innovative breath testing technology.

Cannabix Technologies Inc. is advancing marijuana breathalyzer technology for law enforcement and workplace settings. The Company will present at the Texas Impaired Driving Forum in February 2022, showcasing innovations in their THC breath analyzer devices. The version 4.0 THCBA is undergoing testing, demonstrating improved accuracy and reduced costs. Recent developments include a partnership with Dr. Richard Yost for FAIMS technology. As Germany prepares to legalize cannabis, Cannabix is exploring opportunities in this emerging market. The Company remains focused on ensuring public safety through its innovative solutions.

Cannabix Technologies is advancing its marijuana breathalyzer devices aimed at law enforcement and workplace safety. Recent tests have shown the FAIMS technology effectively isolates THC, providing important data on marijuana impairment. Engineers are working on making the device more portable and battery-powered, ensuring ease of use in the field. The technology aims to enable rapid, on-site testing of breath samples for THC detection, which could significantly enhance public safety by identifying recent cannabis use. The company is in advanced prototype and pre-clinical testing stages.

Cannabix Technologies is advancing its Marijuana Breathalyzer devices, notably the THC Breath Analyzer (THCBA), designed for law enforcement and workplace drug testing. The company is increasing beta testing at a high-volume clinic in the Northwestern US and has shipped units to a biomedical clinic in Ontario. The THCBA tests for recent THC use in under five minutes and is undergoing enhancements for manufacturability and performance. Preliminary discussions with North American manufacturers have commenced, with version 4.0 targeted for production by Q4 2021.

Cannabix Technologies has received a patent from the United States Patent and Trademark Office for its innovative Marijuana Breathalyzer device, designed for law enforcement and workplace applications. The patent, numbered 17/019728, enhances the company's FAIMS technology for detecting THC in breath samples. Cannabix continues to expand its intellectual property portfolio with recent patents from both the USPTO and the Canadian Intellectual Property Office. The breathalyzer aims to provide a reliable method for identifying recent marijuana use and potential impairment.